Baolingbao Biology Co.,Ltd.

SZSE:002286 Voorraadrapport

Marktkapitalisatie: CN¥2.5b

Baolingbao BiologyLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Baolingbao BiologyLtd has a total shareholder equity of CN¥2.0B and total debt of CN¥363.5M, which brings its debt-to-equity ratio to 17.9%. Its total assets and total liabilities are CN¥2.7B and CN¥642.1M respectively. Baolingbao BiologyLtd's EBIT is CN¥109.4M making its interest coverage ratio 13.6. It has cash and short-term investments of CN¥276.7M.

Belangrijke informatie

17.9%

Verhouding schuld/eigen vermogen

CN¥363.52m

Schuld

Rente dekkingsratio13.6x
ContantCN¥276.72m
AandelenCN¥2.03b
Totaal verplichtingenCN¥642.07m
Totaal activaCN¥2.68b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Oct 08
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Sep 30
We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Jul 03
Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Jun 07
Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

Analyse van de financiële positie

Kortlopende schulden: 002286's short term assets (CN¥855.8M) exceed its short term liabilities (CN¥585.5M).

Langlopende schulden: 002286's short term assets (CN¥855.8M) exceed its long term liabilities (CN¥56.5M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 002286's net debt to equity ratio (4.3%) is considered satisfactory.

Schuld verminderen: 002286's debt to equity ratio has reduced from 39.5% to 17.9% over the past 5 years.

Schuldendekking: 002286's debt is well covered by operating cash flow (48.2%).

Rentedekking: 002286's interest payments on its debt are well covered by EBIT (13.6x coverage).


Balans


Ontdek gezonde bedrijven